We have developed new drugs for:
Female Genital Schistosomiasis (FGS)
Uterine Schistosomiasis
Liquid Praziquantel
Patent Approved!!!
Villasel
&
Inlasel
Together we will reach that goal.
We care and every day we are working hard for you.
VILLYA
Pharmaceuticals
VILLYA
Pharmaceuticals
Your partners in health.
A Cure for your life.
Our business is
taking care of you.
Medicine
Modern Research
Innovative thinking
We think outside the box using modern techniques to analyze data to find a cure.
When life is uncertain
We are confident
Villya is constantly working to search for direct causes in a world of uncertainty.
Pharmaceuticals
Action
We are developing pharmaceuticals that are meant to cure not treat putting us out front.
Villasel
U.S. Pat. No. 10,857,151
A drug for Female Vaginal Schistosomiasis (FGS)
Our research has led Villya to the discovery that Female Vaginal Schistosomiasis is a disease having its own biome and needs to be treated as such. Oral Praziquantel does not have the power to penetrate this alone so we have developed our new drug Villasel. This drug works as a topical gel administered directly to the sight of the infection clearing the parasites. Villya designed this drug specifically to eliminate the threat so we combined our two active ingredients to eliminate not only the adult worms but the juveniles and egg!
By eliminating the cause of FGS we are able to save the patient from cervical cancer related to FGS and exposure HIV.
For treatment of Schistosomiasis intrauterine. When schistosomiasis resides beyond the cervix in females and needs to be treated Inlasel can be used to treat schistosomiasis.
